1 Start 2 Complete

After attending this session I can now demonstrate the identified learning objectives *

	Yes	No
Define the role of Th2A cells and serum immunoglobulin E on aspirin treatment outcomes in AERD patients	Define the role of Th2A cells and serum immunoglobulin E on aspirin treatment outcomes in AERD patients - Yes	Define the role of Th2A cells and serum immunoglobulin E on aspirin treatment outcomes in AERD patients - No
Define AERD nasal polyps by the presence of local antibodies	Define AERD nasal polyps by the presence of local antibodies - Yes	Define AERD nasal polyps by the presence of local antibodies - No
Compare transcriptomes of nasal polyps from ethnically diverse patients with and without AERD	Compare transcriptomes of nasal polyps from ethnically diverse patients with and without AERD - Yes	Compare transcriptomes of nasal polyps from ethnically diverse patients with and without AERD - No

The session format and teaching technique were appropriate for the content. *

Yes

No

This session met my expectations based on the session description and learning objectives. *

Yes

No

I observed objective, balanced content that demonstrated no bias in favor of goods or services of a commercial interest. *

Yes

No

Speaker/Moderator was engaging and provided accurate, valuable content *

	Yes	No
Patricia A. Takach, MD, FAAAAI	Patricia A. Takach, MD, FAAAAI - Yes	Patricia A. Takach, MD, FAAAAI - No
Elina Jerschow, MD FAAAAI	Elina Jerschow, MD FAAAAI - Yes	Elina Jerschow, MD FAAAAI - No
Anand Kumar Andiappan, PhD	Anand Kumar Andiappan, PhD - Yes	Anand Kumar Andiappan, PhD - No
Kathleen M. Buchheit, MD	Kathleen M. Buchheit, MD - Yes	Kathleen M. Buchheit, MD - No

If you responded no to any questions, or have other comments about this session, please explain.

Please provide any additional feedback about the faculty in this session:

Leave this field blank